CURE vs. BRKL
CURE (Direxion Daily Healthcare Bull 3x Shares) and BRKL (Corgi BRKB 2x Daily ETF) are both Leveraged Equities funds. CURE is passively managed, while BRKL is actively managed. Their 0.59 correlation means they have sometimes moved together and sometimes differently. CURE charges 0.94%/yr vs 0.45%/yr for BRKL.
Performance
CURE vs. BRKL - Performance Comparison
Loading charts...
Returns By Period
CURE
- 1D
- -0.52%
- 1M
- -4.06%
- 6M
- 6.28%
- YTD
- 6.43%
- 1Y
- 67.78%
- 3Y*
- 7.93%
- 5Y*
- 0.06%
- 10Y*
- 13.34%
- ALL TIME*
- 24.18%
BRKL
- 1D
- 0.36%
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.37K | $14.77K | $14.77K | |
| $8.76M | $9.12M | $9.34M |
CURE vs. BRKL - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -1.03% |
BRKL Corgi BRKB 2x Daily ETF | 1.84% |
Correlation
The correlation between CURE and BRKL is 0.59, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 7, 2026 | 0.59 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. BRKL — Risk / Return Rank
CURE
BRKL
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CURE vs. BRKL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Corgi BRKB 2x Daily ETF (BRKL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | BRKL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.25 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.19 | — | — |
| Martin ratioReturn relative to average drawdown | 4.92 | — | — |
Loading charts...
Drawdowns
CURE vs. BRKL - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than BRKL's maximum drawdown of -7.03%. Use the drawdown chart below to compare losses from any high point for CURE and BRKL.
Loading charts...
Drawdown Indicators
| CURE | BRKL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -7.03% | -62.16% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -15.52% | 0.00% | -15.52% |
Average DrawdownAverage peak-to-trough decline | -18.16% | -3.93% | -14.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.83% | — | — |
Volatility
CURE vs. BRKL - Volatility Comparison
Loading charts...
Volatility by Period
| CURE | BRKL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.88% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 35.22% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 46.17% | 30.17% | +16.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.67% | 30.17% | +14.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.87% | 30.17% | +19.70% |
CURE vs. BRKL - Expense Ratio Comparison
CURE has a 0.94% expense ratio, which is higher than BRKL's 0.45% expense ratio.
Dividends
CURE vs. BRKL - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.07%, while BRKL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BRKL Corgi BRKB 2x Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CURE Direxion Daily Healthcare Bull 3x Shares | 1.07% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
Frequently Asked Questions
CURE and BRKL have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BRKL is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BRKL is cheaper with a 0.45% expense ratio, compared with 0.94% for CURE.
CURE has the higher dividend yield at 1.07%, compared with 0.00% for BRKL.
They also come from different issuers: Direxion and Corgi. Their fees differ too: 0.94% for CURE and 0.45% for BRKL.
Find the right allocation for CURE and BRKL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer